<VariationArchive VariationID="2580980" VariationName="NM_032043.3:c.(2492_2493)_(3750_?)del" VariationType="Deletion" Accession="VCV002580980" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2023-09-30" MostRecentSubmission="2023-09-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2748565" VariationID="2580980">
      <GeneList>
        <Gene Symbol="BRIP1" FullName="BRCA1 interacting helicase 1" GeneID="83990" HGNC_ID="HGNC:20473" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>17q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="61679139" stop="61863528" display_start="61679139" display_stop="61863528" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="59756546" stop="59940919" display_start="59756546" display_stop="59940919" Strand="-" />
          </Location>
          <OMIM>605882</OMIM>
          <Haploinsufficiency last_evaluated="2019-02-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRIP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-02-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRIP1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_032043.3:c.(2492_2493)_(3750_?)del</Name>
      <VariantType>Deletion</VariantType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032043.3" sequenceAccession="NM_032043" sequenceVersion="3" change="c.(2492_2493)_(3750_?)del" MANESelect="true">
            <Expression>NM_032043.3:c.(2492_2493)_(3750_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032043.3:c.(2492_2493)_(3750_?)del AND Familial ovarian cancer" Accession="RCV003330215" Version="3">
        <ClassifiedConditionList TraitSetID="65982">
          <ClassifiedCondition DB="MedGen" ID="C5679802">Familial ovarian cancer</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-03-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-09-30" MostRecentSubmission="2023-09-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="65982" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="51398" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial ovarian cancer</ElementValue>
                <XRef ID="MONDO:0016248" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20467" />
                <XRef ID="20467" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2022">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic version 2.2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg122</URL>
                <CitationText>UK NICE Clinical guideline (CG122), Ovarian cancer: recognition and initial management, 2023</CitationText>
              </Citation>
              <XRef ID="213517" DB="Orphanet" />
              <XRef ID="C5679802" DB="MedGen" />
              <XRef ID="MONDO:0016248" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7555668" SubmissionDate="2023-09-01" DateLastUpdated="2023-09-30" DateCreated="2023-09-30">
        <ClinVarSubmissionID localKey="NM_032043.3:c.(2492_2493)_(3750_?)del|MONDO:16248" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004037235" DateUpdated="2023-09-30" DateCreated="2023-09-30" Type="SCV" Version="1" SubmitterName="Dr. med. U. Finckh, Human Genetics, Eurofins MVZ" OrgID="507663" OrganizationCategory="other" OrgAbbreviation="HuGe Do" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRIP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032043.3:c.(2492_2493)_(3750_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0016248" />
          </Trait>
        </TraitSet>
        <Comment>Deletion of BRIP1 exon 18 to 20. Heterozygous in a proband with triple negative breast cancer and endometrial cancer who had undergone hysterectomy and adnexectomy.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB13808074</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7555668" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0016248" MappingRef="MONDO">
        <MedGen CUI="C5679802" Name="Familial ovarian cancer" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

